US excipients market forecast to rise
US research firm The Freedonia Group has released the report ‘Excipients’, an industry study showcasing trends and forecasts in the pharmaceutical excipients market. The study also analyses market environment factors, evaluates company market share and profiles 47 US industry competitors.
Demand for pharmaceutical excipients in the US is projected to rise 4.3% per year to $2 billion in 2018. In volume terms, demand is expected to grow 1.9% annually to 408,000,000 kg over the same period. While continued growth in pharmaceutical output will be the primary driver of increases in excipient demand, gains will accelerate as excipients play a larger role in bringing additional value to pharmaceutical products by improving properties such as the controlled release or improved absorption of active ingredients.
Trends in pharmaceutical output by dosage formulation will have a strong influence on excipient demand by application. Output of parenteral preparations is expected to rise at an especially strong pace through 2018, supporting demand for suspension agents and preservatives. Solvents are also projected to benefit from increased shipments of parenteral drugs, although gains in dollar terms will be limited by the continued decline in glycerin prices due to oversupply.
Oral preparations are the largest category of pharmaceutical dosage formulations and oral pharmaceuticals tend to require more excipients than other types of drugs; thus, they have a significant impact on excipient demand. Shipments of oral pharmaceuticals are forecast to rise at a faster pace than seen in the 2008-2013 period, supporting accelerated gains in demand for fillers, binders, coatings, flavouring agents, capsules and disintegrants. In addition, oral formulations are expected to boost their market share, further raising demand for excipients such as binders and disintegrants.
US excipient demand (million dollars)
| Item | 2008 | 2013 | 2018 | Annual growth 2008-2013 | Annual growth 2013-2018 |
| Excipient demand | 1405 | 1620 | 2000 | 2.9% | 4.3% |
| Polymers | 596 | 708 | 890 | 3.5% | 4.7% |
| Alcohols | 303 | 331 | 400 | 1.8% | 3.9% |
| Minerals | 123 | 140 | 170 | 2.6% | 4.0% |
| Gelatin | 95 | 111 | 140 | 3.2% | 4.8% |
| Sugars | 38 | 43 | 50 | 2.5% | 3.1% |
| Other | 250 | 287 | 350 | 2.8% | 4.0% |
Product differentiation will play an increasingly important role as generic pharmaceutical products increase their market share and as consumers take a more active role in choosing their drugs from among a wide range of products with the same active pharmaceutical ingredients. Product versatility will be a key factor impacting product mix in excipient demand, especially as specialty excipient blends play an increasingly important role in pharmaceutical formulation. Polymers are expected to benefit from this trend as many of these products can function in multiple applications and are easily formulated with other excipients.
Nominations now open for the 2026 NMI Measurement Awards
Until 20 May, the National Measurement Institute (NMI) is accepting nominations for the 2026 NMI...
Australia to begin treaty negotiations on association to Horizon Europe
To give Australian organisations access to the world's largest pooled research fund in 2027,...
Vaxxas partners with AI company Profenso to support quality assurance
A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in...
